 Anemia, Sickle Cell
"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Descriptor ID |
D000755
|
| MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
| Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Sickle Cell Anemia
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
- Sickling Disorder Due to Hemoglobin S
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in UAMS Profiles by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2022 | 4 | 0 | 4 | | 2021 | 9 | 0 | 9 | | 2020 | 6 | 0 | 6 | | 2019 | 6 | 0 | 6 | | 2018 | 5 | 0 | 5 | | 2017 | 3 | 0 | 3 | | 2016 | 4 | 1 | 5 | | 2015 | 5 | 0 | 5 | | 2014 | 3 | 0 | 3 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 0 | 1 | | 2011 | 2 | 1 | 3 | | 2010 | 2 | 0 | 2 | | 2009 | 1 | 0 | 1 | | 2008 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2004 | 3 | 0 | 3 | | 2001 | 3 | 0 | 3 | | 1998 | 2 | 0 | 2 | | 1997 | 2 | 0 | 2 | | 1996 | 2 | 0 | 2 | | 1995 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 1993 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles over the past ten years.
-
Brothers RO, Turrentine KB, Akbar M, Triplett S, Zhao H, Urner TM, Goldman-Yassen A, Jones RA, Knight-Scott J, Milla SS, Bai S, Tang A, Brown RC, Buckley EM. The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease. Blood. 2024 05 23; 143(21):2145-2151.
-
Chamberlin JH, Ogbonna A, Abrol S, Maisuria D, Miller E, McGuire A, Knight H, O'Doherty J, Baruah D, Schoepf UJ, Munden RF, Kabakus IM. Enhancing diagnostic precision for acute chest syndrome in sickle cell disease: insights from dual-energy CT lung perfusion mapping. Emerg Radiol. 2024 Feb; 31(1):73-82.
-
Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227.
-
Sustich SJ, Stronach BM, Stambough JB, Barnes CL, Mears SC. Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery. Orthop Clin North Am. 2022 Oct; 53(4):421-430.
-
Abdullahi SU, Jibir BW, Bello-Manga H, Gambo S, Inuwa H, Tijjani AG, Idris N, Galadanci A, Hikima MS, Galadanci N, Borodo A, Tabari AM, Haliru L, Suleiman A, Ibrahim J, Greene BC, Ghafuri DL, Rodeghier M, Slaughter JC, Kirkham FJ, Neville K, Kassim A, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. Lancet Haematol. 2022 Jan; 9(1):e26-e37.
-
Espa?ol MG, Gardner RV, Alicea-Marrero MM, Marrero-Rivera G, Bradford T, LeBlanc DM, Velez MC. Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report. J Pediatr Hematol Oncol. 2022 Jan 01; 44(1):e134-e137.
-
Mack JM, Frankowski S, Verkamp B, Crary SE, Spray B, Crawley L, Saccente S, Neville KA. Pupil Size and Reactivity in Pediatric Patients With Sickle Cell Disease. J Pediatr Hematol Oncol. 2023 01 01; 45(1):e44-e47.
-
Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, Achebe MM, Boccia R, Crary SE, Kraft WK, Archer N, Cataldo V, Hardesty BM, Idowu M, Desai PC, Ikeda A, Puthenveetil G, Hassell KL, Sarnaik S, Kutlar A. Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. Br J Haematol. 2021 11; 195(4):e150-e153.
-
Green SE, Singh ZN, Baer MR. Primary myelofibrosis in a patient with sickle cell disease. Am J Hematol. 2022 01 01; 97(1):160-161.
-
Ghafuri DL, Covert Greene B, Musa B, Gambo A, Sani A, Abdullahi S, Wudil BJ, Bello-Manga H, Gambo S, Ghafuri M, Cassell H, Neville K, Kirkham F, Kassim AA, Aliyu MH, DeBaun MR, Jordan LC. Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa. Pediatr Neurol. 2021 12; 125:9-15.
-
Akkus NI, Rajpal S, Hilbun J, Dwary A, Smith TR, Mina G, Reddy PC. Troponin Elevation in Sickle Cell Disease. Med Princ Pract. 2021; 30(5):437-442.
-
Ezihe-Ejiofor A, Jackson J. Peripartum considerations in sickle cell disease. Curr Opin Anaesthesiol. 2021 Jun 01; 34(3):212-217.
-
Jhaveri S, Choueiter N, Manwani D, Ranabothu S, Morrone K, Hafeman M, Reidy K, Kaskel F, Mahgerefteh J. Association of Anemia and Blood Pressure With Novel Markers of Diastolic Function in Pediatric Sickle Cell Disease. J Pediatr Hematol Oncol. 2021 05 01; 43(4):e486-e493.
-
Whittington JR, Magann EF, Ounpraseuth ST, Chang JN, Whitcombe DD, Morrison JC. Evidence for Prophylactic Transfusion during Pregnancy for Women with Sickle Cell Disease. South Med J. 2021 Apr; 114(4):231-236.
-
Strumph K, Hafeman M, Ranabothu S, Gomes W, Benitez S, Kaskel F, Manwani D, Mahgerefteh J. Nocturnal hypertension associated with stroke and silent cerebral infarcts in children with sickle cell disease. Pediatr Blood Cancer. 2021 05; 68(5):e28883.
-
Eisenberg L. A Sickle-Cell Patient Displaced by the Pandemic: Is a Request for Opioids Legitimate, or Sign of a Deeper Problems? Am J Bioeth. 2021 01; 21(1):69-70.
-
Abdullahi SU, Wudil BJ, Bello-Manga H, Musa AB, Gambo S, Galadanci NA, Aminu H, Tijjani Gaya A, Sanusi S, Tabari MA, Galadanci A, Borodo A, Abba MS, Dambatta AH, Haliru L, Gambo A, Cassell H, Rodeghier M, Ghafuri DL, Covert Greene BV, Neville K, Kassim AA, Kirkham F, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial. Pediatr Hematol Oncol. 2021 Feb; 38(1):49-64.
-
Chacon-Portillo MA, Mossad EB, Zea-Vera R, Beckerman Z, Binsalamah ZM, Adachi I, Mery CM, Imamura M, Heinle JS, Fraser CD. Sickle Cell-Related Complications in Patients Undergoing Cardiopulmonary Bypass. World J Pediatr Congenit Heart Surg. 2020 09; 11(5):565-571.
-
Galadanci NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, Aminu H, Tijjani A, Abba MS, Tabari MA, Galadanci A, Borodo AM, Belonwu R, Salihu AS, Rodeghier M, Ghafuri DL, Covert C Greene BV, Neville K, Kassim AA, Kirkham FJ, Jordan LC, Aliyu MH, DeBaun MR. Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial. Am J Hematol. 2020 09; 95(9):E247-E250.
-
Creary S, Chisolm D, Stanek J, Neville K, Garg U, Hankins JS, O'Brien SH. Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease. Pediatr Blood Cancer. 2020 08; 67(8):e28250.
-
Brown B, Long K, Agdere L, Kulpa J, Zarzoso-Fernandez S, Choudhary D, Sundarum R. The association between vitamin D deficiency and hospitalization outcomes in pediatric patients with sickle cell disease. Blood Cells Mol Dis. 2020 05; 82:102415.
-
Singh A, Dasgupta M, Simpson PM, Brousseau DC, Panepinto JA. Can PROMIS domains of pain and physical functioning detect changes in health over time for children with sickle cell disease? Pediatr Blood Cancer. 2020 05; 67(5):e28203.
-
McCarty TR, Sharma P, Yadav S, Ngu JN, Njei B. Response to Letter to the Editor: Impact of Bariatric Surgery on Outcomes of Patients with Sickle Cell Disease: a Nationwide Inpatient Sample Analysis, 2004-2014. Obes Surg. 2019 08; 29(8):2624.
-
Karafin MS, Mullins DE, Johnson ST, Nischik D, Feng M, Simpson P, Field JJ. Chronic pain persists in adults with sickle cell disease despite regular red cell transfusions. Transfus Apher Sci. 2019 Aug; 58(4):434-438.
-
Sharma P, McCarty TR, Yadav S, Ngu JN, Njei B. Impact of Bariatric Surgery on Outcomes of Patients with Sickle Cell Disease: a Nationwide Inpatient Sample Analysis, 2004-2014. Obes Surg. 2019 06; 29(6):1789-1796.
-
Karafin MS, Chen G, Wandersee NJ, Brandow AM, Hurley RW, Simpson P, Ward D, Li SJ, Field JJ. Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain. PLoS One. 2019; 14(5):e0216994.
-
Ahmed J, Kumar A, Jafri F, Batool S, Knoll B, Lim SH. Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell Disease. N Engl J Med. 2019 02 28; 380(9):887-888.
-
Singh A, DasGupta M, Simpson PM, Panepinto JA. Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease. Pediatr Blood Cancer. 2019 05; 66(5):e27633.
-
Chang JN, Magann EF, Novotny SA, Cooley CE, Gauss CH, Parrish MR, Morrison JC. Maternal/Perinatal Outcome in Women with Sickle Cell Disease: A Comparison of Two Time Periods. South Med J. 2018 12; 111(12):742-745.
-
Myers CF, Ipe TS. Bone Marrow Necrosis in Sickle Cell-Beta Thalassemia Patient Mimicking Thrombotic Thrombocytopenic Purpura. Ann Clin Lab Sci. 2018 Sep; 48(5):670-673.
-
Akanbi O, Adejumo AC, Saleem N, Francisque F, Soliman M, Ogunbayo GO. Sickle cell disease is associated with higher mortality among patients hospitalized with ischemic bowel disease. Eur J Gastroenterol Hepatol. 2018 09; 30(9):1027-1032.
-
Kumar A, Ahmed J, Anwar A, Fanucchi M, Lim SH. Applicability of and potential barriers preventing allogeneic stem cell transplant in sickle cell patients treated outside a sickle cell program. Am J Hematol. 2018 06; 93(6):E150-E152.
-
Majumdar S, Tirona R, Mashegu H, Desai J, Shannon NT, Summar M, Cunningham G, Darbari D, Nickel R, Campbell A, Barr FE. A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis. Br J Haematol. 2019 02; 184(4):634-636.
-
Patterson GD, Mashegu H, Rutherford J, Seals S, Josey D, Karlson C, McNaull M, May W, Carroll C, Barr FE, Majumdar S. Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: Clinical Features and Risk Factors. J Pediatr Hematol Oncol. 2018 01; 40(1):51-55.
-
Estepp JH, Wiczling P, Moen J, Kang G, Mack JM, Liem R, Panepinto JA, Garg U, Kearns G, Neville KA. Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure. Br J Clin Pharmacol. 2018 07; 84(7):1478-1485.
-
Ogunbayo GO, Misumida N, Olorunfemi O, Elbadawi A, Saheed D, Messerli A, Elayi CS, Smyth SS. Comparison of Outcomes in Patients Having Acute Myocardial Infarction With Versus Without Sickle-Cell Anemia. Am J Cardiol. 2017 Nov 15; 120(10):1768-1771.
-
Galadanci NA, Umar Abdullahi S, Vance LD, Musa Tabari A, Ali S, Belonwu R, Salihu A, Amal Galadanci A, Wudil Jibir B, Bello-Manga H, Neville K, Kirkham FJ, Shyr Y, Phillips S, Covert BV, Kassim AA, Jordan LC, Aliyu MH, DeBaun MR. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial). Am J Hematol. 2017 Aug; 92(8):780-788.
-
Kaur H, Muhleman M, Balon HR. Spleen Uptake on a Bone Scan. J Nucl Med Technol. 2017 Sep; 45(3):245-246.
-
Johnson K, Pulley L. Interest in Treatment of Patients with Sickle Cell Disease: A Brief Survey of Arkansas Physicians. J Ark Med Soc. 2017 Jan; 113(7):160-163.
-
Eisenbrown K, Nimmer M, Ellison AM, Simpson P, Brousseau DC. Which Febrile Children With Sickle Cell Disease Need a Chest X-Ray? Acad Emerg Med. 2016 11; 23(11):1248-1256.
-
Cai C, Nedosekin DA, Menyaev YA, Sarimollaoglu M, Proskurnin MA, Zharov VP. Photoacoustic Flow Cytometry for Single Sickle Cell Detection In Vitro and In Vivo. Anal Cell Pathol (Amst). 2016; 2016:2642361.
-
Galanzha EI, Viegas MG, Malinsky TI, Melerzanov AV, Juratli MA, Sarimollaoglu M, Nedosekin DA, Zharov VP. In vivo acoustic and photoacoustic focusing of circulating cells. Sci Rep. 2016 Mar 16; 6:21531.
-
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease. JACC Cardiovasc Imaging. 2016 Mar; 9(3):243-52.
-
Olson M, Hebson C, Ehrlich A, New T, Sachdeva R. Tissue Doppler Imaging-derived Diastolic Function Assessment in Children With Sickle Cell Disease and Its Relation With Ferritin. J Pediatr Hematol Oncol. 2016 Jan; 38(1):17-21.
-
Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Jason Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter SD, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML, Rice HE. Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia. J Pediatr Surg. 2016 Jan; 51(1):122-7.
-
Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA. Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. J Clin Pharmacol. 2016 Mar; 56(3):298-306.
-
Ipe TS, Wilkes JJ, Hartung HD, Westhoff CM, Chou ST, Friedman DF. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease. J Pediatr Hematol Oncol. 2015 Mar; 37(2):e135-7.
-
Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA. Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. Am J Hematol. 2015 Feb; 90(2):139-43.
-
Neville KA, Panepinto JA. Pharmacotherapy of Sickle Cell Disease in Children. Curr Pharm Des. 2015; 21(39):5660-7.
-
Pandey S, Cottler-Fox M, Drobena G. Hemoglobin Variants Acquired Post-Exchange Transfusion in Pediatric Sickle Cell Disease (SCD) Patients. Ann Clin Lab Sci. 2015; 45(6):627-30.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|